Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Clinical trial NCT02475629 · COMPLETED
Trial details
- NCT number
- NCT02475629
- Sponsor
- TaiMed Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.